111 related articles for article (PubMed ID: 9365753)
21. Imaging efficacy of a hepatocyte-selective polyiodinated triglyceride for contrast-enhanced computed tomography.
Bakan DA; Doerr-Stevens JK; Weichert JP; Longino MA; Lee FT; Counsell RE
Am J Ther; 2001; 8(5):359-65. PubMed ID: 11550077
[TBL] [Abstract][Full Text] [Related]
22. Monochromatic Spectral Computed Tomography with Low Iodine Concentration Contrast Medium in a Rabbit VX2 Liver Model:: Investigation of Image Quality and Detection Rate.
Zhou Y; Xu H; Hou P; Dong JQ; Wang MY; Gao JB
Acad Radiol; 2016 Apr; 23(4):486-95. PubMed ID: 26795435
[TBL] [Abstract][Full Text] [Related]
23. Comparative accuracy of intravenous contrast-enhanced CT versus noncontrast CT plus intravenous contrast-enhanced CT in the detection and characterization of patients with hypervascular liver metastases: a critically appraised topic.
Sadigh G; Applegate KE; Baumgarten DA
Acad Radiol; 2014 Jan; 21(1):113-25. PubMed ID: 24331274
[TBL] [Abstract][Full Text] [Related]
24. Combined hepatocyte-selective and blood-pool contrast agents for the CT detection of experimental liver tumors in rabbits.
Weichert JP; Lee FT; Chosy SG; Longino MA; Kuhlman JE; Heisey DM; Leverson GE
Radiology; 2000 Sep; 216(3):865-71. PubMed ID: 10966724
[TBL] [Abstract][Full Text] [Related]
25. Micro-CT imaging with a hepatocyte-selective contrast agent for detecting liver metastasis in living mice.
Kim HW; Cai QY; Jun HY; Chon KS; Park SH; Byun SJ; Lee MS; Oh JM; Kim HS; Yoon KH
Acad Radiol; 2008 Oct; 15(10):1282-90. PubMed ID: 18790400
[TBL] [Abstract][Full Text] [Related]
26. Magnetic starch microspheres in the MR imaging of hepatic metastases. A preclinical study in the nude rat.
Sundin A; Wang C; Ericsson A; Fahlvik AK
Acta Radiol; 1998 Mar; 39(2):161-6. PubMed ID: 9529447
[TBL] [Abstract][Full Text] [Related]
27. Effect of patient weight and scanning duration on contrast enhancement during pulmonary multidetector CT angiography.
Bae KT; Tao C; Gürel S; Hong C; Zhu F; Gebke TA; Milite M; Hildebolt CF
Radiology; 2007 Feb; 242(2):582-9. PubMed ID: 17255426
[TBL] [Abstract][Full Text] [Related]
28. Gastric cancer with synchronous and metachronous hepatic metastasis predicted by enhancement pattern on multiphasic contrast-enhanced CT.
Tsurumaru D; Nishimuta Y; Muraki T; Asayama Y; Nishie A; Oki E; Honda H
Eur J Radiol; 2018 Nov; 108():165-171. PubMed ID: 30396650
[TBL] [Abstract][Full Text] [Related]
29. Material density hepatic steatosis quantification on intravenous contrast-enhanced rapid kilovolt (peak)-switching single-source dual-energy computed tomography.
Patel BN; Kumbla RA; Berland LL; Fineberg NS; Morgan DE
J Comput Assist Tomogr; 2013; 37(6):904-10. PubMed ID: 24270112
[TBL] [Abstract][Full Text] [Related]
30. Automatic detection and classification of hypodense hepatic lesions on contrast-enhanced venous-phase CT.
Bilello M; Gokturk SB; Desser T; Napel S; Jeffrey RB; Beaulieu CF
Med Phys; 2004 Sep; 31(9):2584-93. PubMed ID: 15487741
[TBL] [Abstract][Full Text] [Related]
31. Feasibility of interstitial CT lymphography using optimized iodized oil emulsion in rats.
Chung YE; Hyung WJ; Kweon S; Lim SJ; Choi J; Lee MH; Kim H; Myoung S; Lim JS
Invest Radiol; 2010 Mar; 45(3):142-8. PubMed ID: 20065857
[TBL] [Abstract][Full Text] [Related]
32. Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET.
Sahani DV; Kalva SP; Fischman AJ; Kadavigere R; Blake M; Hahn PF; Saini S
AJR Am J Roentgenol; 2005 Jul; 185(1):239-46. PubMed ID: 15972430
[TBL] [Abstract][Full Text] [Related]
33. The influence of different contrast medium concentrations and injection protocols on quantitative and clinical assessment of FDG-PET/CT in lung cancer.
Verburg FA; Kuhl CK; Pietsch H; Palmowski M; Mottaghy FM; Behrendt FF
Eur J Radiol; 2013 Oct; 82(10):e617-22. PubMed ID: 23880426
[TBL] [Abstract][Full Text] [Related]
34. Pancreatic CT imaging: effects of different injection rates and doses of contrast material.
Kim T; Murakami T; Takahashi S; Okada A; Hori M; Narumi Y; Nakamura H
Radiology; 1999 Jul; 212(1):219-25. PubMed ID: 10405745
[TBL] [Abstract][Full Text] [Related]
35. Quantification of tumor uptake of iodized oils and emulsions of iodized oils: experimental study.
de Baere T; Zhang X; Aubert B; Harry G; Lagrange C; Ropers J; Dufaux J; Lumbroso J; Rougier P; Ducreux M; Roche A
Radiology; 1996 Dec; 201(3):731-5. PubMed ID: 8939223
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of a Gadolinium-Based Nanoparticle (AGuIX) for Contrast-Enhanced MRI of the Liver in a Rat Model of Hepatic Colorectal Cancer Metastases at 9.4 Tesla.
Fries P; Morr D; Müller A; Lux F; Tillement O; Massmann A; Seidel R; Schäfer T; Menger MD; Schneider G; Bücker A
Rofo; 2015 Dec; 187(12):1108-15. PubMed ID: 26361379
[TBL] [Abstract][Full Text] [Related]
37. Hepatic metastasis detection: comparison of three CT contrast enhancement methods.
Miller DL; Simmons JT; Chang R; Ward BA; Shawker TH; Doppman JL; Chang AE
Radiology; 1987 Dec; 165(3):785-90. PubMed ID: 3685361
[TBL] [Abstract][Full Text] [Related]
38. Detectability of Brain Metastases by Using Frequency-Selective Nonlinear Blending in Contrast-Enhanced Computed Tomography.
Bongers MN; Bier G; Schabel C; Fritz J; Horger M
Invest Radiol; 2019 Feb; 54(2):98-102. PubMed ID: 30281555
[TBL] [Abstract][Full Text] [Related]
39. Pancreas: patient body weight tailored contrast material injection protocol versus fixed dose protocol at dynamic CT.
Yanaga Y; Awai K; Nakayama Y; Nakaura T; Tamura Y; Hatemura M; Yamashita Y
Radiology; 2007 Nov; 245(2):475-82. PubMed ID: 17890356
[TBL] [Abstract][Full Text] [Related]
40. Detection of hepatic steatosis on contrast-enhanced CT images: diagnostic accuracy of identification of areas of presumed focal fatty sparing.
Lawrence DA; Oliva IB; Israel GM
AJR Am J Roentgenol; 2012 Jul; 199(1):44-7. PubMed ID: 22733892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
